| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PBANKA_1413600
|
| Gene Model P. falciparum ortholog |
PF3D7_1315100
|
| Gene product | serine/threonine protein kinase PK9 |
| Gene product: Alternative name | |
| top of page |
| Details of the genetic modification |
| Inducable system used | No |
| Additional remarks inducable system |
|
| Type of plasmid/construct used | (Linear) plasmid double cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
|
| Partial or complete disruption of the gene | Complete |
| Additional remarks partial/complete disruption |
|
| Selectable marker used to select the mutant parasite | hdhfr |
| Promoter of the selectable marker | eef1a |
| Selection (positive) procedure | pyrimethamine |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | For the deletion of Pk9, a replacement construct was generated as described previously (Mastan et al., 2017). For this, target sequences F8 and F9 were amplified using primers 1016/1017 and 1018/1019 specific for the 5′ or 3′ flanking regions respectively. The F8 (0.62 kb) and F9 (0.62 kb) were cloned in plasmid pBC-GFP-hDHFR at XhoI/ClaI and NotI/AscI restriction sites respectively. The targeting construct was digested with XhoI/AscI |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences 
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | |
| Additional information primer 1 | |
| Sequence Primer 2 | |
| Additional information primer 2 | |
| Sequence Primer 3 | |
| Additional information primer 3 | |
| Sequence Primer 4 | |
| Additional information primer 4 | |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
| top of page |